SK Biopharmaceuticals Co. Ltd Financials

Market Capitalization ₩8.591 Trillion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-260.00
Forward PE	63.39
Price to Sales TTM	₩18.47
Price to Book MRQ	₩
Enterprise to Revenue	15.96
Enterprise to EBITDA	129.02

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	7.27%
Operating Margin	19.44%
Return on Assets TTM	3.47%
Return on Equity TTM	7.41%

Income Statement

Revenue TTM	₩465,064,263,680
Revenue per Share TTM	₩5938.51
Quarterly Revenue Growth	74.00%
Gross Profit TTM	₩423,603,208,192
EBITDA	₩177,336,942,660
Net Income to Common TTM	₩33,796,192,256
Diluted EPS TTM	₩-420.00
Quarterly Earnings Growth YoY	51.21%

Balance Sheet

Total Cash MRQ	₩286,451,597,312
Total Cash per Share MRQ	₩3657.77
Total Debt MRQ	₩
Total Debt to Equity MRQ	55.51
Current Ratio MRQ	1.64
Book Value per Share MRQ	₩

Cash Flow

Operating Cash Flow TTM	₩-6,748,972,544
Levered Free Cash Flow TTM	₩-15,349,228,544

326030 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	78,313,200
Float Shares	28,055,722
Avg 10 Volume	264,335
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	64.19%
% Held by Institutions	12.68%

Stock Price Summary

Beta	0.91
Fifty Two Week Low	₩72600.00
Fifty Two Week High	₩130000.00
Fifty Two Week Change	14.01%
Day 50 MA	₩106082.00
Day 200 MA	₩97218.00

Dividends and Splits

Forward Annual Dividend Rate	₩
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	₩
Trailing Annual Dividend Yield	%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date